Funder
National Natural Science Foundation of China
National Science and Technology Major Project
National Key R&D Program of China
grants from the Jiangsu Province of China
Key R&D Program of Jiangsu Province
Jiangsu Natural Science Foundation
Natural Science Foundation of the Jiangsu Higher Education Institution of China
Jiangsu Medical Outstanding Talents Project
Jiangsu Provincial Key Medical Center
Translational Research Grant of NCRCH
Priority Academic Program Development of Jiangsu Higher Education Institutions
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Lewis RE, Cruse JM, Sanders CM, Webb RN, Suggs JL. Aberrant expression of T-cell markers in acute myeloid leukemia. Exp Mol Pathol. 2007;83:462–3.
2. Ochi K, Fuji S, Takano K, Tajima K, Ito A, Tanaka T, et al. The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemia. Bone Marrow Transplant. 2018;53:1019–29.
3. Tien HF, Chou CC, Wang CH, Chang CH, Hsing CC. Putative normal counterparts of leukaemic cells from CD7-positive acute myeloid leukaemia can be demonstrated in human haemopoietic tissues. Br J Haematol. 1996;94:501–6.
4. Chang H, Yeung J, Brandwein J, Yi QL. CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype. Leuk Res. 2007;31:157–62.
5. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, et al. Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma. Blood. 1993;81:2399–405.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献